ProfileGDS5822 / ILMN_2837025
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 99% 99% 98% 99% 98% 99% 99% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 14335.499
GSM1276600PDAC Late Ablation Control 23766.499
GSM1276601PDAC Late Ablation Control 33854.298
GSM1276602PDAC Late Ablation 13937.999
GSM1276603PDAC Late Ablation 23566.998
GSM1276604PDAC Late Ablation 35779.399
GSM1303940PDAC Late Ablation_anti-CTLA4 14694.999
GSM1303941PDAC Late Ablation_anti-CTLA4 24159.498
GSM1303942PDAC Late Ablation_anti-CTLA4 33495.398